Pharmocann
Pharmocann is an Israeli medical cannabis cultivation company founded in 2008, based in Jezreel, publicly listed on the Tel Aviv Stock Exchange (PMCN). The firm operated as a small licensed cannabis producer, though its current operational status is uncertain given an inactive corporate website.
- Company typePrivate
- Founded2008
- HeadquartersJezreel, Israel
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
Pharmocann firmographics
Firmographics- Name
- Pharmocann
- Website
- https://pharmocann.com
- Company type
- Private
- Founded year
- 2008
- Operating status
- Closed
- Headcount range
- 11–50 employees
- Short description
- Pharmocann is an Israeli medical cannabis cultivation company founded in 2008, based in Jezreel, publicly listed on the Tel Aviv Stock Exchange (PMCN). The firm operated as a small licensed cannabis producer, though its current operational status is uncertain given an inactive corporate website.
- Ownership category
- akta.pro rank
Pharmocann industry classification
Industry- Product category
- Medical Cannabis Pharmaceuticals
- NAICS
- Pharmaceutical Preparation Manufacturing (325412)
- SIC
- Pharmaceutical Preparations (2834)
- akta.pro primary industry
- Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services) (CRANAFAI)
- akta.pro secondary industry
- Compounding Pharmacies (Sterile/Non-Sterile) (HLAFALAE)
Keywords
Where Pharmocann is headquartered
LocationHeadquarters
- HQ city
- Jezreel
- HQ country
- Israel
- HQ region
- Middle East
Markets served
Pharmocann business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Infrastructure
Pharmocann product offering
Product offeringCore offering
Pharmocann is an Israeli pharmaceutical company that develops and produces medical cannabis. The company cultivates medical cannabis on a farm located in Jezreel, Israel, and operates as a publicly traded entity on the Tel Aviv Stock Exchange (ticker: PMCN).
Differentiator
Problem solved
Functional benefit
Products and services
- Israeli Medical Cannabis
Companies that use Pharmocann
Customer profileIdeal customer profiles1 record
Pharmocann technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Pharmocann competitors and assessment
Company assessmentBroad incumbents
- Canopy Growth Corporation: Global cannabis operator with medical cannabis cultivation, including German and other international medical channels; broadly comparable in cultivation-pharma targeting.
- Jazz Pharmaceuticals (GW Pharmaceuticals legacy): Owner of cannabinoid-based prescription medicines (Sativex, Epidiolex); comparable through the pharmaceutical-grade medical cannabis delivery model Pharmocann positions itself within.
- Aurora Cannabis: Global cannabis producer with strong European medical cannabis footprint; provides a comparable benchmark for medical-cultivation and export revenue mix.
- Tilray Brands: Large multi-jurisdictional cannabis operator with a medical division; references the medical cannabis cultivation and international export model Pharmocann operates in.
Direct peers
- Tikun Olam (Canndoc): One of Israel's largest licensed medical cannabis cultivators and pharmacy suppliers; directly comparable in cultivation, pharmacy supply, and Israeli export channel.
- Panaxia Pharmaceutical Industries: Israeli pharma-grade medical cannabis producer focused on dosage forms, clinical-grade manufacturing, and exports — directly mirrors Pharmocann's 'pharmaceutical cannabis cultivator' positioning.
- IM Cannabis (IMC): Israeli-licensed medical cannabis producer and brand operator (including the Tikun Olam Canndoc brand), serving the same Israeli patient market with cultivation and export ambitions.
- Bazelet Group: Israeli medical cannabis cultivator and pharmacy supplier serving both domestic and export markets; comparable in size and licensing profile to Pharmocann.
- Seach Medical Group: Israeli medical cannabis cultivator and IMC-GAP licensed supplier active in the same patient and export channels as Pharmocann.
Emerging players
- Cannabotech: Israel-based biotech developing cannabinoid-based therapeutic products; comparable through its pharma-style formulation and dosing focus on medical cannabis.
Market position
Customer concentration
Pharmocann social profiles
Digital presencePharmocann financial estimates
Financial estimateRevenue estimate
Valuation estimate
Pharmocann leadership team
Management profileNumber of profiles
Profiles1 record
Pharmocann funding detail
Funding detailFunding overview
Funding rounds1 record
Investors1 record
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Pharmocann M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Pharmocann
What does Pharmocann do?
Pharmocann is an Israeli pharmaceutical company that develops and produces medical cannabis. The company cultivates medical cannabis on a farm located in Jezreel, Israel, and operates as a publicly traded entity on the Tel Aviv Stock Exchange (ticker: PMCN).
Is Pharmocann a public or private company?
Pharmocann is a private company. It is classified as public and is currently closed.
When was Pharmocann founded?
Pharmocann was founded in 2008. It employs 11 to 50 people.
Where is Pharmocann based?
Pharmocann is headquartered in Jezreel, Israel, in the Middle East region.
Who are Pharmocann's main competitors?
Broad incumbents on record are Canopy Growth Corporation, Jazz Pharmaceuticals (GW Pharmaceuticals legacy), Aurora Cannabis and Tilray Brands. Direct peers are Tikun Olam (Canndoc), Panaxia Pharmaceutical Industries, IM Cannabis (IMC), Bazelet Group and Seach Medical Group. Cannabotech is listed as an emerging player.
Does Pharmocann have an API?
No public API is recorded for Pharmocann.
What industry is Pharmocann in?
Pharmocann's product category is Medical Cannabis Pharmaceuticals. Its primary akta.pro industry code is CRANAFAI, Cannabis Dispensary + Pharmacy/Clinical Model (Patient Services), with a secondary code of HLAFALAE, Compounding Pharmacies (Sterile/Non-Sterile). Its NAICS code is 325412 and its SIC code is 2834.